BTGGF:OTC-BTG International Ltd (USD)

COMMON STOCK | Other | OTC

Last Closing Price

USD 10.05

Change

0.00 (0.00)%

Market Cap

USD 3.96B

Average Target Price

N/A
Average Analyst Rating

N/A

Fundamental Analysis

Verdict

About

BTG plc acquires, develops, manufactures, and commercializes pharmaceutical products in the United States, Europe, and internationally. It operates through two segments, Product and Licensing. The company offers oncology products and systems, such as beads and TheraSphere for treatment of liver cancer; and cryoablation technology for use in kidney cancer. It also provides vascular products consisting of EKOS blood clot treatment devices; arterial blockage crossing devices; Varithena for the treatment of varicose veins; and sentry inferior vena cava filters. In addition, the company offers acute care products, such as CroFab, DigiFab, and Voraxaze. Further, it provides Zytiga for treatment of prostate cancer; Two-Part Hip Cup; and Lemtrada. The company was formerly known as British Technology Group International plc and changed its name to BTG plc in March 1995. BTG plc was founded in 1948 and is headquartered in London, the United Kingdom.

Employees : 1,724

Fiscal Year End : March

Currency: USD

Country : USA

Technical Indicators

Beta : 0.33

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-01-25 )

Largest Industry Peers for Other

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
SSNLF Samsung Electronics Co., Ltd

N/A

 USD15,011.80B 9.00 N/A
DISPF Disco Corporation

N/A

 USD3,369.71B 18.60 -488.90
BMYMP Bristol-Myers Squibb Company P..

N/A

 USD1,841.23B 4,990.00 N/A
CHKDJ Chesapeake Energy Corporation ..

N/A

 USD1,315.84B N/A N/A
BAMKL Bank of America Corporation

N/A

 USD267.26B 9.28 N/A
JGSMY JG Summit Holdings, Inc

N/A

 USD205.43B 43.38 0.27
NCRRP NCR Corporation 5.5% PFD CNV A

N/A

 USD169.92B 1,197.30 N/A
BPHLY Bank of the Philippine Islands

N/A

 USD160.15B 15.34 N/A
UNLNF Unilever N.V

N/A

 USD158.01B 24.49 N/A
LLOBF Lloyds Banking Group plc 9.25%..

N/A

 USD134.80B N/A N/A

ETFs Containing BTGGF

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Other)		 Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain 17.54% N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 17.54% N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 6.65% N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.65% N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 21.22% N/A N/A N/A N/A
Risk Adjusted Return 31.32% N/A N/A N/A N/A
Market Capitalization 3.96B N/A N/A N/A N/A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Other)		 Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 35.26 N/A N/A N/A N/A
Price/Book Ratio N/A N/A N/A N/A N/A
Price / Cash Flow Ratio 29.39 N/A N/A N/A N/A
EV/EBITDA N/A N/A N/A N/A N/A
Management Effectiveness  
Return on Equity N/A N/A N/A N/A N/A
Return on Invested Capital 14.03% N/A N/A N/A N/A
Return on Assets N/A N/A N/A N/A N/A
Debt to Equity Ratio N/A N/A N/A N/A N/A
Technical Ratios  
Short Ratio N/A N/A N/A N/A N/A
Short Percent N/A N/A N/A N/A N/A
Beta 0.33 N/A N/A N/A N/A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Positive cash flow

The company had positive total cash flow in the most recent four quarters.

What to not like:

There is nothing we particularly dislike